Evidence map›Paper›PMID 21866173›Full record

ArticleNature reviews. Immunology2011

Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease?

Caroline Jefferies, Claire Wynne, Rowan Higgs

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature reviews. Immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Caroline JefferiesMolecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, 123 St. Stephen's Green, Dublin 2, Ireland. cjefferies@rcsi.ie
Claire Wynne
Rowan Higgs
Royal College of Surgeons in Ireland · IETrinity College Dublin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The concept that viral sensing systems, via their ability to drive pro-inflammatory cytokine and interferon production, contribute to the development of autoimmune and autoinflammatory disease is supported by a wide range of clinical and experimental observations. Recently, the tripartite motif-containing proteins (TRIMs) have emerged as having key roles in antiviral immunity - either as viral restriction factors or as regulators of pathways downstream of viral RNA and DNA sensors, and the inflammasome. Given their involvement in these pathways, we propose that TRIM proteins contribute to the development and pathology of autoimmune and autoinflammatory conditions, thus making them potential novel targets for therapeutic manipulation.

Indexed as

AnimalsAntiviral Restriction FactorsAutoimmune DiseasesCarrier ProteinsDNA-Binding ProteinsHereditary Autoinflammatory DiseasesHumansInflammasomesInterferonsMiceMinor Histocompatibility AntigensRepressor ProteinsRibonucleoproteinsRING Finger DomainsSS-A AntigenTranscription FactorsAntiviral Restriction FactorsCarrier ProteinsDNA-Binding ProteinsInflammasomesInterferonsMinor Histocompatibility AntigensRepressor ProteinsRibonucleoproteinsSS-A AntigenTranscription FactorsTRIM16 protein, humanTRIM22 protein, humanTRIM28 protein, humanTRIM5 protein, humanTripartite Motif-Containing Protein 28Tripartite Motif ProteinsUbiquitin-Protein Ligases

Identifiers

PMID21866173
OpenAlexW2032684576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.